Tag: affimed

December 4, 2018

5 Top NASDAQ Biotech Stocks Year-to-Date

Nearing the end of the year and Q4, the Investing News Network looks at the top-gaining NASDAQ biotech stocks so...
March 20, 2018

Affimed Reports Financial Results for Fourth Quarter and Year End 2017

Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies, today reported...
February 16, 2018

Affimed Announces Closing of Public Offering of Common Stock and Exercise of Underwriters’ Option to Purchase Additional Shares

Affimed (Nasdaq:AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies, today announced the closing...
February 13, 2018

Affimed Announces Proposed Public Offering of Common Stock

Affimed (Nasdaq: AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies, today announced that...
February 1, 2018

Affimed Reports New Data for AFM13 from Two Separate Clinical Trials in Hodgkin and CD30-Positive Lymphomas

Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies, today reported...
January 11, 2017

Affimed Provides Update on NK-Cell Immuno-Oncology Platform

Affimed N.V. (Nasdaq:AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies, today provided an...
November 9, 2016

Affimed to Present at the Jefferies 2016 London Healthcare Conference

Affimed, a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies, announced today that Dr. Adi...